Product Description
Mouse anti-human IgG is used to label ABEI, and use purified Rubella antigen to coat nano magnetic microbeads. Sample, Calibrator or Control with Buffergoat Anti-human IgM, goat Anti-human IgA and nano magnetic microbeads coated with Rubella antigen are mixed thoroughly and incubated at 37 and cycle washing for 1 time. Then add ABEI Label, incubation and form a sandwich, then washing for the 2nd time. Subsequently, the starter reagents are added and a flash chemiluminescent reaction is initiated. The light signal is measured by a photomultiplier as RLU within 3 seconds and is proportional to the concentration of Rubella IgG present in samples Technical Details 
Advanced Chemiluminescence Immunoassay TechnologyMaglumi Rubella IgG kit applies sophisticated CLIA technology, ensuring precise and sensitive detection of IgG antibodies to Rubella virus. The indirect approach stabilizes assay results, minimizing interference and false readings. Laboratories benefit from consistent quantitation across a wide measurement range (0.25 - 200 IU/mL), boosting confidence in immunity status evaluations.
Streamlined Laboratory WorkflowThis kit is specifically engineered for automated immunoassay analyzers, supporting real-time operation. It integrates seamlessly into laboratory routines, with simple calibration using master curves and user-friendly reagents. Positive and negative controls are included, facilitating robust validation for each run and ensuring lab professionals meet quality standards.
Reliable and Rapid ResultsMaglumi provides clinicians with results in approximately 30 minutes, accelerating diagnostic decision-making and patient care. Its high accuracy and ready-to-use format eliminate elaborate preparations, enhancing throughput and productivity in busy diagnostic laboratories.
FAQ's of Maglumi Rubella IgG kit:
Q: How does the Maglumi Rubella IgG kit detect IgG antibodies to Rubella virus?
A: The kit employs an indirect chemiluminescence immunoassay (CLIA) principle, utilizing specific reagents and buffer solutions to quantitatively detect IgG antibodies in human serum or plasma. The automated analyzer measures the emitted light proportional to antibody concentration.
Q: What is the intended use of the Maglumi Rubella IgG kit?
A: It is designed for professional in-vitro diagnostic use, allowing laboratories to quantitatively assess IgG antibodies against Rubella virus in human serum or plasma samples, helping determine immunity status or past infection.
Q: Where is the kit typically used and what type of samples are needed?
A: This kit is used in clinical laboratories with fully automated CLIA analyzers. It requires serum or plasma samples collected from patients for analysis.
Q: When can results be obtained after running the assay?
A: Results are available in approximately 30 minutes after the sample is processed through the automated immunoassay system, facilitating rapid clinical decisions.
Q: What is the calibration process for this kit?
A: Calibration is performed with a two-point calibration method using a master curve stored within the system, ensuring accurate measurement of IgG antibody levels in each test cycle.
Q: How should the kit be stored and what is its shelf life?
A: The kit should be stored at 2-8C and must not be frozen. Its shelf life is 12 months from the date of manufacture, maintaining reagent stability and reliability throughout its usage period.
Q: What benefits does the Maglumi Rubella IgG kit offer to laboratory professionals?
A: The kit provides high sensitivity and specificity, rapid results, easy-to-use reagents, included controls for internal validation, and reliable quantitation across a broad measurement range. This ensures consistent, accurate diagnostics and streamlined workflow integration.